AMP® HF Inaugural Meeting
The Accelerating Medicines Partnership® (AMP®) Program in Heart Failure (HF) Inaugural Meeting will be held on September 29, 2022 at the Gaylord National Resort and Convention Center in National Harbor, Maryland.
The AMP HF Program, a public-private partnership facilitated by the FNIH, will advance our understanding of heart failure with preserved ejection fraction using two complementary and integrated research components: analyzing existing HFpEF datasets, sourced from public and private sector funded studies, and initiating a new clinical trial to confirm retrospective findings in an observational cohort with a goal to develop a framework for new precision treatments.
2022-23 Research Skills Trainees
The HeartShare Research Skills Program trainees for the 2022-2023 academic year have been announced. They have started their 3-month bootcamp to receive hands-on training in data management, programming, and application of machine learning and artificial intelligence approaches to clinical research in data science. They will spend the remaining 9 months in the program to complete a mentored research project related to HFpEF, using the approaches they learned in the data science bootcamp.
For more information about the program and to meet the trainees visit the “Research Skills Program” page or click the link below.
Nature Reviews Drug Discovery – AMP HF
FNIH AMP® HF Launch Announcement
AMP HF Inaugural Meeting